These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38953805)

  • 1. Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study.
    Agarwal A; Maharshi V
    Indian J Public Health; 2024 Apr; 68(2):194-200. PubMed ID: 38953805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India.
    Bashar A; Nandekar SV; Shrivastava P; Singh RN; Srikrishnan P
    J Vector Borne Dis; 2023; 60(3):307-316. PubMed ID: 37843242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration.
    Derua YA; Kisinza WN; Simonsen PE
    Parasit Vectors; 2018 Jul; 11(1):429. PubMed ID: 30029675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
    Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
    Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
    Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
    de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana.
    Dicko I; Coulibaly YI; Sangaré M; Sarfo B; Nortey PA
    Infect Disord Drug Targets; 2020; 20(2):167-174. PubMed ID: 30727921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
    Babu BV; Babu GR
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):538-49. PubMed ID: 24728444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
    Lahariya C; Mishra A
    J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana.
    Biritwum NK; Yikpotey P; Marfo BK; Odoom S; Mensah EO; Asiedu O; Alomatu B; Hervie ET; Yeboah A; Ade S; Hinderaker SG; Reid A; Takarinda KC; Koudou B; Koroma JB
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):690-695. PubMed ID: 28938053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
    da Silva JSF; Braga C; Duarte FM; Oliveira P; Feitosa Luna C; Marcondes M; Araújo J; Grilis MR; de Souza Melo PFA; Brandão E; Rocha A
    Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.
    Manyeh AK; Ibisomi L; Ramaswamy R; Baiden F; Chirwa T
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0007009. PubMed ID: 32804967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
    Roy RN; Sarkar AP; Misra R; Chakroborty A; Mondal TK; Bag K
    J Health Popul Nutr; 2013 Jun; 31(2):171-7. PubMed ID: 23930334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
    Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
    Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
    Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti.
    Mathieu E; Lammie PJ; Radday J; Beach MJ; Streit T; Wendt J; Addiss DG
    Ann Trop Med Parasitol; 2004 Oct; 98(7):703-14. PubMed ID: 15509424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
    Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
    Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.